Estimate of anti-Plasmodium falciparum sporozoite activity in humans vaccinated with synthetic circumsporozoite protein (NANP)3

Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):748-50. doi: 10.1016/0035-9203(89)90315-5.

Abstract

A mathematical model was defined to estimate the degree of in vivo activity against Plasmodium falciparum sporozoites expressed by volunteers vaccinated with a synthetic peptide comprising the immunodominant epitope of the circumsporozoite protein. Relative to the course of infection in non-immunized controls, infections in vaccinated volunteers corresponded to the neutralization or delay of development of greater than 99% of challenge sporozoites.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Humans
  • Malaria / prevention & control*
  • Models, Theoretical
  • Oligopeptides / administration & dosage*
  • Plasmodium falciparum / growth & development*
  • Plasmodium falciparum / immunology
  • Vaccination
  • Vaccines, Synthetic / therapeutic use

Substances

  • Oligopeptides
  • Vaccines, Synthetic
  • (asparaginyl-alanyl-asparaginyl-proline)3